PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

NCT04174339 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Gastric Adenocarcinoma

Interventions

DRUG: Camrelizumab
DRUG: Apatinib Mesylate
DRUG: POF

Sponsor

Fujian Cancer Hospital